The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Spain approves AstraZeneca COVID-19 vaccine for 18-55 year-olds

Fri, 05th Feb 2021 17:38

(Recasts to lead with vaccine approval)

MADRID, Feb 5 (Reuters) - Spain approved AstraZeneca's
coronavirus vaccine for use in people aged 18 to 55 on
Friday, becoming the latest country to limit the shot to younger
people due to a lack of data on its use among the elderly.

Italy also recommends its preferential use for adults of 55
and under, while Germany, France, Austria and Norway will only
administer the shot to people younger than 65.

Separately, Madrid confirmed on Friday the region's first
case of the Brazilian COVID-19 variant, while the national
health ministry said it was not aware of any other cases of the
highly contagious strain on Spanish territory.

Catalan authorities announced Spain's second known case of
the South African variant on Wednesday, a day after the
government restricted air travel with Brazil and South Africa to
curb the spread of the virulent new strains from those
countries.

A third wave of COVID-19 infections has been slowing, with
Spain's 14-day incidence rate falling to 751 cases per 100,000
people on Friday from 900 cases in late January, but officials
say the arrival of the new strains could drive a resurgence.

The health ministry recorded 28,565 new cases on Friday,
bringing the total above 2.94 million, while the death toll
climbed by 584 to 61,386.

"IT'S VERY CONFUSING"

In an initial phase aimed at protecting care-home residents
and workers and front-line medics, Spain has administered 1.87
million doses produced by Pfizer and Moderna.

It expects a delivery of 1.8 million AstraZeneca doses in
February to speed up the pace of inoculation and help it hit a
target of vaccinating 70% of the population by summer.

Nearly three quarters of Spaniards are willing to receive a
shot as soon as one became available, according to a poll by the
Centre for Sociological Studies (CIS) but some remain wary.

"At the moment I will not get one. I will wait a bit," said
80-year old retired lawyer Livigno, out walking in central
Madrid. "You hear positive and negative comments and it's very
confusing. I am not even sure the government is clear."

In one rare bit of good news from the COVID frontline, two
patients recovering from the virus, Fernando, 70, and Rosario,
62, got married at Madrid's Hospital Isabel Zendal after he
proposed to her via WhatsApp. They were married by a priest via
videolink.

(Reporting by Nathan Allen and Graham Keeley
Editing by Ingrid Melander and Gareth Jones)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.